» Articles » PMID: 27510531

Intracellular Calcium Increases in Vascular Smooth Muscle Cells with Progression of Chronic Kidney Disease in a Rat Model

Overview
Date 2016 Aug 12
PMID 27510531
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vascular smooth muscle cells (VSMCs) exhibit phenotypic plasticity, promoting vascular calcification and increasing cardiovascular risk. Changes in VSMC intracellular calcium ([Ca 2+ ] i ) are a major determinant of plasticity, but little is known about changes in [Ca 2+ ] i in chronic kidney disease (CKD). We have previously demonstrated such plasticity in aortas from our rat model of CKD and therefore sought to examine changes in [Ca 2+ ] i during CKD progression.

Materials And Methods: We examined freshly isolated VSMCs from aortas of normal rats, Cy/+ rats (CKD) with early and advanced CKD, and advanced CKD rats treated without and with 3% calcium gluconate (CKD + Ca 2+ ) to lower parathyroid hormone (PTH) levels. [Ca 2+ ] i was measured with fura-2.

Results: Cy/+ rats developed progressive CKD, as assessed by plasma levels of blood urea nitrogen, calcium, phosphorus, parathyroid hormone and fibroblast growth factor 23. VSMCs isolated from rats with CKD demonstrated biphasic alterations in resting [Ca 2+ ] i : VSMCs from rats with early CKD exhibited reduced resting [Ca 2+ ] i , while VSMCs from rats with advanced CKD exhibited elevated resting [Ca 2+ ] i . Caffeine-induced sarcoplasmic reticulum (SR) Ca 2+ store release was modestly increased in early CKD and was more drastically increased in advanced CKD. The advanced CKD elevation in SR Ca 2+ store release was associated with a significant increase in the activity of the sarco-endoplasmic reticulum Ca 2+ ATPase (SERCA); however, SERCA2a protein expression was decreased in advanced CKD. Following SR Ca 2+ store release, recovery of [Ca 2+ ] i in the presence of caffeine and extracellular Ca 2+ was attenuated in VSMCs from rats with advanced CKD. This impairment, together with reductions in expression of the Na + /Ca 2+ exchanger, suggest a reduction in Ca 2+ extrusion capability. Finally, store-operated Ca 2+ entry (SOCE) was assessed following SR Ca 2+ store depletion. Ca 2+ entry during recovery from caffeine-induced SR Ca 2+ store release was elevated in advanced CKD, suggesting a role for exacerbated SOCE with progressing CKD.

Conclusions: With progressive CKD in the Cy/+ rat there is increased resting [Ca 2+ ] i in VSMCs due, in part, to increased SOCE and impaired calcium extrusion from the cell. Such changes may predispose VSMCs to phenotypic changes that are a prerequisite to calcification.

Citing Articles

The mechanosensitive Piezo1 channels contribute to the arterial medial calcification.

Szabo L, Balogh N, Toth A, Angyal A, Gonczi M, Csiki D Front Physiol. 2022; 13:1037230.

PMID: 36439266 PMC: 9685409. DOI: 10.3389/fphys.2022.1037230.


Phenotypic plasticity of vascular smooth muscle cells in vascular calcification: Role of mitochondria.

Liu Y, Li Z, Zhang L, Wang D, Liu Y Front Cardiovasc Med. 2022; 9:972836.

PMID: 36312244 PMC: 9597684. DOI: 10.3389/fcvm.2022.972836.


Oxidative Stress Related to Plasmalemmal and Mitochondrial Phosphate Transporters in Vascular Calcification.

Nguyen N, Nguyen T, Park K Antioxidants (Basel). 2022; 11(3).

PMID: 35326144 PMC: 8944874. DOI: 10.3390/antiox11030494.


Non-Additive Effects of Combined NOX1/4 Inhibition and Calcimimetic Treatment on a Rat Model of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Damrath J, Chen N, Metzger C, Srinivasan S, ONeill K, Biruete A JBMR Plus. 2022; 6(3):e10600.

PMID: 35309859 PMC: 8914155. DOI: 10.1002/jbm4.10600.


Vascular Calcification Mechanisms: Updates and Renewed Insight into Signaling Pathways Involved in High Phosphate-Mediated Vascular Smooth Muscle Cell Calcification.

Abbasian N Biomedicines. 2021; 9(7).

PMID: 34356868 PMC: 8301440. DOI: 10.3390/biomedicines9070804.


References
1.
Neven E, DHaese P . Vascular calcification in chronic renal failure: what have we learned from animal studies?. Circ Res. 2011; 108(2):249-64. DOI: 10.1161/CIRCRESAHA.110.225904. View

2.
Moe S, Drueke T, Lameire N, Eknoyan G . Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis. 2007; 14(1):3-12. DOI: 10.1053/j.ackd.2006.10.005. View

3.
Gutierrez O, Januzzi J, Isakova T, Laliberte K, Smith K, Collerone G . Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 2009; 119(19):2545-52. PMC: 2740903. DOI: 10.1161/CIRCULATIONAHA.108.844506. View

4.
Lajdova I, Spustova V, Oksa A, Kaderjakova Z, Chorvat Jr D, Morvova Jr M . The Impact of Vitamin D3 Supplementation on Mechanisms of Cell Calcium Signaling in Chronic Kidney Disease. Biomed Res Int. 2015; 2015:807673. PMC: 4434177. DOI: 10.1155/2015/807673. View

5.
Berra-Romani R, Mazzocco-Spezzia A, Pulina M, Golovina V . Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am J Physiol Cell Physiol. 2008; 295(3):C779-90. PMC: 2544451. DOI: 10.1152/ajpcell.00173.2008. View